Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04253145
Title Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fundacion Oncosur

lung small cell carcinoma


Atezolizumab + Lurbinectedin

Age Groups: senior | adult
Covered Countries

No variant requirements are available.